TD Asset Management »

Odyssey Therapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Odyssey Therapeutics shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Odyssey Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Odyssey Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Odyssey Therapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $545k 29k 18.71

More positions owned by TD Asset Management

NVIDIA Corporation (NVDA)
Rbc Cad (RY)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Bank Of Montreal Cadcom (BMO)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Cibc Cad (CM)
Broadcom (AVGO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Enbridge (ENB)
Amazon (AMZN)
Manulife Finl Corp (MFC)
Canadian Pacific Kansas City (CP)
Johnson & Johnson (JNJ)

View all positions for TD Asset Management

Top funds holding Odyssey Therapeutics

Sanofi
Standard Life Aberdeen
TD Asset Management

View all funds holding Odyssey Therapeutics